ME/CFS Evidence Browser — Classified Studies on Myalgic Encephalomyelitis

221–240 of 280 studies

E3 PreliminaryCohortPEM requiredCase-Control

A case of post-COVID-19 myalgic encephalomyelitis/chronic fatigue syndrome characterized by post-exertional malaise and low serum acylcarnitine level.

Jinushi, Ryuhei, Nishiguchi, Sho, Masuda, Sakue et al.·Clinical case reports·2023

This study describes a patient who developed ME/CFS after recovering from COVID-19. The researchers found that this patient had lower-than-normal levels of acylcarnitine, a substance the body uses to produce energy. The study reviews existing research on how COVID-19 can lead to ME/CFS, a condition that causes severe fatigue and symptoms that worsen after physical activity.

BiomarkersPost-Exertional Malaise

E3 PreliminaryReviewPEM not requiredReview-Narrative

Role of Tau protein in long COVID and potential therapeutic targets.

Marwaha, Bharat·Frontiers in cellular and infection microbiology·2023

Long COVID causes ongoing fatigue, breathing problems, brain fog, and other symptoms that can last months or years. This review suggests that a protein called tau—which is known to damage the brain in other diseases—may also be involved in Long COVID. The authors propose that future research should look for tau damage in Long COVID patients and that treatments designed to stop tau buildup might help.

NeuroinflammationBiomarkers

E3 PreliminaryCommentaryPEM unclear

Long-COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): Potential neurophysiological biomarkers for these enigmatic entities.

Versace, Viviana, Tankisi, Hatice·Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2023

This editorial discusses potential nerve-based tests that might help identify and distinguish Long-COVID and ME/CFS—two conditions that share similar exhaustion and brain symptoms but are still poorly understood. The authors review existing neurophysiological tools (tests that measure nerve and muscle function) that could potentially serve as objective biomarkers to help doctors diagnose these conditions more reliably. They highlight the need for further research to validate these tests and better understand what's happening in patients' nervous systems.

Biomarkers

E3 PreliminaryMechanismPEM unclearCross-Sectional

Detection of Elevated Level of Tetrahydrobiopterin in Serum Samples of ME/CFS Patients with Orthostatic Intolerance: A Pilot Study.

Gottschalk, Carl Gunnar, Whelan, Ryan, Peterson, Daniel et al.·International journal of molecular sciences·2023

This study looked at a molecule called BH4 in the blood of ME/CFS patients, particularly those who experience dizziness when standing up. The researchers found that ME/CFS patients have higher levels of BH4 than healthy people, and this may be connected to oxidative stress (harmful chemical reactions in the body). This finding could help explain why some ME/CFS patients struggle with dizziness and blood flow problems.

Biomarkers

E3 PreliminaryDiagnosticPEM unclearMethods-Paper

Bayesian Statistics Improves Biological Interpretability of Metabolomics Data from Human Cohorts.

Brydges, Christopher, Che, Xiaoyu, Lipkin, Walter Ian et al.·Metabolites·2023

This study compared blood chemistry samples from three different groups of ME/CFS patients and healthy people to find differences in metabolites—small molecules in the blood. Instead of using the traditional statistical method, researchers used a newer approach called Bayesian statistics that allows them to combine results from multiple studies to find patterns that traditional methods missed. They discovered several important differences in blood metabolites between ME/CFS patients and healthy controls, including abnormal fat molecules and reduced levels of prostaglandin F2alpha.

Biomarkers

E3 PreliminaryMechanismPEM not requiredCross-Sectional

No Signs of Neuroinflammation in Women With Chronic Fatigue Syndrome or Q Fever Fatigue Syndrome Using the TSPO Ligand [11C]-PK11195.

Raijmakers, Ruud, Roerink, Megan, Keijmel, Stephan et al.·Neurology(R) neuroimmunology & neuroinflammation·2022

Researchers used a specialized brain scan to look for signs of inflammation in the brains of women with ME/CFS and Q fever fatigue syndrome, compared to healthy women. The scan didn't find evidence of the type of brain inflammation they were looking for, which contradicts some earlier research suggesting inflammation might play a role in these conditions.

NeuroinflammationBiomarkersImmune System

E3 PreliminaryMechanismPEM requiredCross-Sectional

Diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome With Partial Least Squares Discriminant Analysis: Relevance of Blood Extracellular Vesicles.

González-Cebrián, Alba, Almenar-Pérez, Eloy, Xu, Jiabao et al.·Frontiers in medicine·2022

Researchers tested whether tiny particles called extracellular vesicles in blood could help diagnose ME/CFS. They analyzed various substances in blood from patients and healthy controls using a computer analysis method. The study found that certain features of these blood particles, combined with other markers, could potentially identify ME/CFS, though more testing is needed to confirm this works reliably in larger groups.

Biomarkers

E3 PreliminaryMechanismPEM unclearCross-Sectional

Altered endothelial dysfunction-related miRs in plasma from ME/CFS patients.

Blauensteiner, J, Bertinat, R, León, L E et al.·Scientific reports·2021

This study looked at tiny molecules called microRNAs in the blood of ME/CFS patients to understand what might be going wrong with their blood vessels. The researchers found that five specific microRNAs were higher in ME/CFS patients compared to healthy people, and these molecules are known to affect how blood vessels function. This discovery suggests that blood vessel problems might be part of what causes ME/CFS symptoms.

BiomarkersImmune System

E3 PreliminaryMechanismPEM not requiredMechanistic

Broadband electrical impedance as a novel characterization of oxidative stress in single L6 skeletal muscle cells.

Ferguson, Caroline, Pini, Niccolo, Du, Xiaotian et al.·Analytica chimica acta·2021

This study tested whether a special electrical measurement could detect damage from oxidative stress (harmful chemical reactions) in muscle cells. Researchers treated rat muscle cells with hydrogen peroxide to create oxidative stress, then measured how these stressed cells behaved electrically compared to healthy cells. The stressed cells showed distinctly different electrical patterns, suggesting this technology might one day help diagnose ME/CFS by detecting oxidative stress in patients' muscle cells.

Biomarkers

E3 PreliminaryReviewPEM requiredReview-Narrative

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): An Overview.

Deumer, Undine-Sophie, Varesi, Angelica, Floris, Valentina et al.·Journal of clinical medicine·2021

ME/CFS is a long-term illness that causes extreme tiredness, worsening of symptoms after activity, and difficulty thinking clearly. Patients experience these symptoms very differently from one another, and currently there are no blood tests or physical exams that can definitively diagnose the condition. This review examines several potential causes, including past infections, genetic factors, hormone imbalances, and changes in gut bacteria, while exploring whether a simple blood test might someday help diagnose ME/CFS.

BiomarkersPost-Exertional Malaise

E3 PreliminaryReviewPEM unclearReview-Narrative

Radiation exposure and mitochondrial insufficiency in chronic fatigue and immune dysfunction syndrome.

Rusin, Andrej, Li, Megan, Cocchetto, Alan et al.·Medical hypotheses·2021

This paper explores the idea that ME/CFS may be caused by damage to mitochondria—the energy-producing parts of cells—possibly triggered by radiation exposure or other environmental stressors like viruses or toxins. When mitochondria cannot produce enough energy, cells throughout the body struggle, and neighboring tissues try to compensate, which may explain why ME/CFS patients experience widespread symptoms like fatigue and immune problems.

Biomarkers

E3 PreliminaryDiagnosticPEM unclearMethods-Paper

Evaluation of natural killer cell assay performance on shipped blood specimens.

Querec, Troy D, Abrams, Joseph, Stewart, Jennifer J et al.·Journal of immunological methods·2021

This study tested different laboratory methods for measuring natural killer (NK) cell function—an immune system measurement that may be important for ME/CFS—using blood samples that were shipped overnight instead of tested immediately. Researchers compared three different testing approaches and found that two of them (CRCA and FCCA) gave similar results when blood samples were processed a day after collection, suggesting these tests could work for clinical settings where samples need to be shipped.

BiomarkersImmune System

E3 PreliminaryPEM unclearRegistry-Resource

mapMECFS: a portal to enhance data discovery across biological disciplines and collaborative sites.

Mathur, Ravi, Carnes, Megan U, Harding, Alexander et al.·Journal of translational medicine·2021

Researchers created mapMECFS, an online database that brings together research information about ME/CFS from scientists around the world. Instead of having data scattered across different locations and websites, this portal allows researchers to easily find, share, and compare information about the disease in one place. This tool is designed to help scientists discover patterns and connections that might reveal new ways to diagnose and treat ME/CFS.

Biomarkers

E3 PreliminaryCommentaryPEM unclearEditorial

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: When Suffering Is Multiplied.

Komaroff, Anthony L·Healthcare (Basel, Switzerland)·2021

ME/CFS is a real illness with measurable biological problems in the body, even though standard blood tests often appear normal. Over the past 20 years, advanced research tools have found objective abnormalities in people with ME/CFS. Unfortunately, many doctors aren't aware of this evidence, which can lead them to dismiss patients' symptoms and wrongly suggest there's nothing physically wrong—adding emotional harm on top of the already serious illness.

Biomarkers

E3 PreliminaryMechanismPEM requiredMechanistic

Profile of circulating microRNAs in myalgic encephalomyelitis and their relation to symptom severity, and disease pathophysiology.

Nepotchatykh, Evguenia, Elremaly, Wesam, Caraus, Iurie et al.·Scientific reports·2020

This study looked at tiny molecules called microRNAs in the blood of severely ill ME/CFS patients before and after a stress challenge designed to trigger post-exertional malaise (the worsening of symptoms after activity). The researchers found that eleven different microRNAs changed in response to this challenge, with patterns that varied depending on symptom severity. These microRNA signatures could potentially be used one day as blood tests to help diagnose ME/CFS.

BiomarkersPost-Exertional Malaise

E3 PreliminaryMechanismPEM unclearMechanistic

Changes in circulating microRNA after recumbent isometric yoga practice by patients with myalgic encephalomyelitis/chronic fatigue syndrome: an explorative pilot study.

Takakura, Shu, Oka, Takakazu, Sudo, Nobuyuki·BioPsychoSocial medicine·2019

This small study tested whether a gentle form of yoga (practiced lying down with adjustable resistance) could help ME/CFS patients feel less tired. Nine patients with ME/CFS who hadn't improved with standard treatment practiced this yoga for 3 months. Their fatigue scores improved significantly, and their blood showed changes in tiny molecules called microRNAs that may be related to how the yoga helped reduce their tiredness.

Biomarkers

E3 PreliminaryMechanismPEM unclearObservational

Epstein-Barr Virus Induced Gene-2 Upregulation Identifies a Particular Subtype of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.

Kerr, Jonathan R·Frontiers in pediatrics·2019

This study found that about 38-55% of ME/CFS patients have higher levels of a specific gene called EBI2 turned on in their immune cells. Patients with this EBI2 pattern appear to have more severe symptoms and different antibody levels compared to other ME/CFS patients. Because EBI2 is known to affect both immune function and brain function, finding this subtype could help explain why ME/CFS patients experience such different symptoms and may lead to new treatments.

BiomarkersImmune System

E3 PreliminaryDiagnosticPEM unclearMethods-Paper

Assessing cellular energy dysfunction in CFS/ME using a commercially available laboratory test.

Tomas, Cara, Lodge, Tiffany A, Potter, Michelle et al.·Scientific reports·2019

This study tested a blood test called the Mitochondrial Energy Score (MES) that is marketed to diagnose ME/CFS by measuring how well cells produce energy. Researchers repeated the test in both ME/CFS patients and healthy people and found no difference between the two groups. They also discovered that waiting even 24 hours before processing blood samples changed the test results significantly, suggesting the test is not reliable enough to use for diagnosis.

Biomarkers

E3 PreliminaryDiagnosticPEM unclearMethods-Paper

Establishment and evaluation of prediction model for multiple disease classification based on gut microbial data.

Bang, Sohyun, Yoo, DongAhn, Kim, Soo-Jin et al.·Scientific reports·2019

Researchers used artificial intelligence to analyze bacteria in the gut of patients with six different diseases, including ME/CFS, to see if gut bacteria patterns could help identify which disease a person has. They tested different computer learning methods and found that looking at bacteria at the genus level (a specific classification of microorganisms) worked best, and they identified certain bacterial groups that might serve as disease markers.

BiomarkersGut Microbiome

E3 PreliminaryReviewPEM unclearReview-Narrative

[History of Researches on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome].

Watanabe, Yasuyoshi, Kuratsune, Hirohiko·Brain and nerve = Shinkei kenkyu no shinpo·2018

This review summarizes research on ME/CFS conducted in Japan since the disease was first identified there in 1990. Scientists have been searching for objective biological markers to help diagnose ME/CFS and understand what causes it. Recent brain imaging studies found evidence of immune cell activation in the brains of ME/CFS patients, which may be linked to the severity of their symptoms.

NeuroinflammationBiomarkers

← Previous Next 20 studies →

Or browse by topic

PEM Immune Neuro Metabolic Biomarkers Severe ME Long COVID Cognitive

Evidence Atlas

Evidence browser

A case of post-COVID-19 myalgic encephalomyelitis/chronic fatigue syndrome characterized by post-exertional malaise and low serum acylcarnitine level.

Role of Tau protein in long COVID and potential therapeutic targets.

Long-COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): Potential neurophysiological biomarkers for these enigmatic entities.

Detection of Elevated Level of Tetrahydrobiopterin in Serum Samples of ME/CFS Patients with Orthostatic Intolerance: A Pilot Study.

Bayesian Statistics Improves Biological Interpretability of Metabolomics Data from Human Cohorts.

No Signs of Neuroinflammation in Women With Chronic Fatigue Syndrome or Q Fever Fatigue Syndrome Using the TSPO Ligand [11C]-PK11195.

Diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome With Partial Least Squares Discriminant Analysis: Relevance of Blood Extracellular Vesicles.

Altered endothelial dysfunction-related miRs in plasma from ME/CFS patients.

Broadband electrical impedance as a novel characterization of oxidative stress in single L6 skeletal muscle cells.

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): An Overview.

Radiation exposure and mitochondrial insufficiency in chronic fatigue and immune dysfunction syndrome.

Evaluation of natural killer cell assay performance on shipped blood specimens.

mapMECFS: a portal to enhance data discovery across biological disciplines and collaborative sites.

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: When Suffering Is Multiplied.

Profile of circulating microRNAs in myalgic encephalomyelitis and their relation to symptom severity, and disease pathophysiology.

Changes in circulating microRNA after recumbent isometric yoga practice by patients with myalgic encephalomyelitis/chronic fatigue syndrome: an explorative pilot study.

Epstein-Barr Virus Induced Gene-2 Upregulation Identifies a Particular Subtype of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.

Assessing cellular energy dysfunction in CFS/ME using a commercially available laboratory test.

Establishment and evaluation of prediction model for multiple disease classification based on gut microbial data.

[History of Researches on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome].

Curated Collections

Neuroinflammation Evidence

Metabolism & Mitochondria

Biomarkers

PEM-Specific Research